Category

Cohort News

FDA Clearance Granted for First AI-Powered Medical Device to Detect All Three Common Skin Cancers (Melanoma, Basal Cell Carcinoma and Squamous Cell Carcinoma)

//
Categories
MIAMI–(BUSINESS WIRE)–DermaSensor Inc. announces FDA clearance for its real-time, non-invasive skin cancer evaluation system. For the first time, the 300,000 primary care physicians in the U.S. can now be equipped to provide quantitative, point-of-care testing for all types of skin...
Read More →

Darmiyan Receives FDA Approval for BrainSee, the First Prognostic Test for Predicting Likelihood of Progression to Alzheimer’s Dementia

//
Categories
FDA’s De Novo approval of BrainSee represents a major advancement in Alzheimer’s diagnostics. Utilizing cutting-edge image processing and medical AI, BrainSee establishes a new standard for predicting progression from amnestic mild cognitive impairment (aMCI) to Alzheimer’s dementia. This breakthrough is...
Read More →

Dental robotics company Neocis raises $20M

//
Categories
Neocis, maker of surgical technology for robot-assisted dental implants, announced today that it raised $20 million in additional funding. Maimi-based Neocis received investments from Mirae Asset Capital/Mirae Asset Venture Investment. They have an affiliation with the Mirae Asset Financial group...
Read More →